30 Major Future Challenges in Evidence, Pricing & Access and How to Overcome Them
Discover the 30 major Market Access challenges that will need to be overcome if, in a healthcare world that is evolving rapidly, real world outcomes are to meet the theoretical promises.
Much has been written about the current trends in healthcare, often punctuated with buzzwords, including: Real World Evidence (RWE), health data, patient engagement, health equity, advanced analytics and, more recently, artificial intelligence.
However, less has been written about the consequences of these trends for health outcomes, or the challenges that may arise from them in terms of the affordability and sustainability of healthcare systems, and the growth and profitability of the healthcare industry (pharma, biotech, medical technology, hardware and software).
Based on research we recently presented at the World Evidence, Pricing & Access Congress, we have identified 30 major challenges that will need to be overcome if, in a healthcare world that is evolving rapidly, real world outcomes are to meet the theoretical promises.
Along the way we propose solutions (approaches that companies and healthcare systems need to consider), identify key facilitators, and finally conclude that the status quo is not an option.
Success will require significant systemic, stakeholder and organisational change.
